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Objective: To describe trends in the prevalence of HIV-1 infection in different popu- 
lations in Gabon, and the molecular characteristics of circulating HIV strains. 
Methods: Data were collected on HIV prevalence through sentinel surveillance sur- 
veys in different populations in Libreville (the capital) and in Franceville. In Libreville, 
a total of 7082 individuals (hospitalized patients, tuberculosis patients, pregnant 
women, asymptomatic adults, prisoners) were recruited between 1986 and 1994. In 
Franceville, we tested 771 pregnant women and 886 healthy asymptomatic adults 
(1 986-1 988). Sera were screened for HIV antibodies by enzyme-linked immunosor- 
bent assay (ELISA) and confirmed by Western blot or line immunoassay (LIA). Reactive 
samples in ELISA were tested for the presence of antibodies to HIV-1 group O viruses 
by ELISA using V3 peptides from HIV-1ANT-70 and HlV-lMv,,.j,80 followed by confir- 
mation by LIA and a specific Western blot. Seventeen HIV-1 strains were isolated 
(1 988-1993) and a 900 base-pair fragment encoding the env region containing V3, 
V4, VS and beginning of gp41 was sequenced and a phylogenetic tree was con- 
structed. 
Results: HIV prevalence was relatively low and remained stable (0.7-1.6% in preg- 
nant women, 2.1-2.2O/0 in the general population). The prevalence was also stable 
among prisoners (2.1-2.6%). Among hospitalized and tuberculosis patients preva- 
lence was higher and increased (1.8-1 2.7% and 1.5-1 6.2%, respectively). Only three 
sera had antibodies to HIV-1 group O. The 17 HIV-1 strains represent six different 
genetic subtypes including type O. 
Conclusion: Our data from 1986 to 1994 show a stable and low HIV prevalence in 
Gabon, and a high genetic diversity of HIV-1 strains. This, also observed in Cameroon, 
is in contrast to that found elsewhere in Africa. Differences in rate of spread of HlV 
infection are probably explained by interplay between numerous factors. The role of 
different HIV subtypes in the dynamics of the HIV epidemic should be examined fur- 
ther. 
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Introduction 
The course of the HIV/AIDS epidemic has shown wide 
variations between different regions in sub-Saharan 
Africa. In some Central African towns, such as Kinshasa 
(Zaïre), HIV prevalence among pregnant women has 
remained relatively low and stable since the nlid-l980s, 
but in o thg  large towns, such as Kampala (Uganda), 
Lusaka (Zambia) and Blantyre (Malawi), the epidemic 
has been explosive with HIV prevalence levels in preg- 
nant women now well above 20% [1,2]. In all regions of 
sub-Saharan Mica the predominant mode of HIV trans- 
mission is through sexual intercourse between men and 
women. The reasons for the heterogeneity in the spread 
of HIV infection are poorly understood. Various factors 
can influence the efficiency of sexual transmission and 
can therefore play a role in the dynamics of HIV infec- 
tion: patterns of risk behaviour, the incidence of other 
sexually transmitted diseases (STD), several demographic 
variables, and circumcision, which is considered a major 
factor [l-51. The efficiency of HIV transmission can 
depend on biological factors: viral load, during early and 
large stages of the infection, may be raised severalfold [6]. 
The role of Werent HIV strains in the dynamics of the 
HIV epidemic remains the subject of controversy. There 
are strong suggestions that HIV-1 is more transmissible 
than HIV-2, which would explain why HIV-2 remains 
less prevalent than HIV-1 [7]. In terms of HIV-1 sub- 
types, recent data fiom Thailand suggest that HIV-1 sub- 
type E may be more easily transmitted through hetero- 
se.wal contact than HIV-1 subtype B [SI. 
There are two main groups of HIV-1, as determined by 
phylogenetic analysis of geographically divergent iso- 
lates: group M and group O. Group M, the major group, 
comprises at least nine different genetic subtypes (A to I) 
[9], all of which have been described in African patients. 
HIV-1 group O viruses are highly divergent HIV-1 
viruses and have so far been found mainly in Cameroon 
or people fi-om Cameroon living in France [10,11]. 
Our knowledge on the geographical distribution of the 
different HIV-1 genotypes in Africa is incomplete, but 
the few data that are available suggest that the relative 
prevalence of each genotype differs from region to 
region [12]. It has been suggested that these differences 
in the distribution of HIV-1 subtypes could explain, at 
least in part, the wide variations in the-_course.pf the HIT? 
epidemic in sub-Saharan Africa. d' 
Surveillance of HIV infection in different population 
groups was started in Gabon, WesternA,E'¿uatorial Africa, 
in 1986. It soon became clear that there is a large variety 
of HIV strains, including HIV-2 and group O strains, 
circulating in the population of Gabon [13-151. Further- 
more chimpanzees naturally infected by an HIV-1-like 
virus [16,17] were origindy found in Gabon. These 
observations have led to speculation on the origins and 
evolution of HIV viruses in this part of the world. 
1: 
1 8 -; * '>  r ; ' 5' t t .t 
- I 
In this study we describe trends in the prevalence of 
HIV-1 infection in different populations in Gabon since 
the start of sentinel surveillance in 1986, as well as the 
niolecular characteristics of circulating HIV strains. 
Materials and methods 
Study population 
Gabon is.situated in Western Equatorial Africa and has a 
population of about 1.2 million inhabitants. During the 
last decade, the population of Gabon became mainly 
urban. In Libreville, the capital city, the population 
ranged fiom 200 O00 inhabitants in 1980 to 450 O00 
inhabitants in 1994; 75% of the population lives in urban 
areas. A high number of immigrants (about 200 000) are 
h i n g  in the main towns of Gabon, mostly h m  neigh- 
bouring countries and West Mica.  
Data were collected on HIV prevalence through planned 
random surveys in different populations in Libreville and 
Francede, which is situated in a semi-rural area in the 
south-eastern part of the country. In Libreville, a random 
selection of patients admitted to the Infectious Diseases 
Department of the General Hospital was tested each year 
fi-om 1988 to 1994 (n = 864); random samples of tuber- 
culosis patients were screened between 1990 and 1994 
(n = 177). Sentinel surveillance among pregnant women 
attending antenatal clinics around Libreville provided 
prevalence data for 1988,1993 and 1994 (n = 2753). In 
addition, in each of the years 1986, 1988 and 1989 a 
population-based survey was carried out on HIV preva- 
lence among adults (n = 1180). 
The methods of these surveys are described in more 
detail elsewhere [13,18]. In each of these surveys 
between 350 and 400 adults in the age group 15-49 
years were randomly selected &om the general popula- 
tion by two-stage cluster sampling [13,18]. In 1986 and 
1994 a survey among prisoners (n = 1808) was also car- 
ried out. In Franceville, data were collected on pregnant 
women in 1986 and 1987 (n = 771), and general popu- 
lation surveys were carried out in 1986 and 1988 
(n = 886). 
HIV serology 
Sera were screened for the presence of HIV antibodies 
by either one of the following enzyme-linked immun- 
osorbent assays (ELISA): Elavia m k t  or Genelavia mivt 
(Diagnostics Pasteur, Marnes-La-Coquette, France); HIV 
ELIGA (Dypont-de-Nemours, Wellington, Delaware, 
USA); Vironostica (Organon Teknika, Oss, The Nether- 
lands); or Innotest HIV-l/HIV-2 (Innogenetics, Ghent, 
Belgium). Reactive samples were confirmed either by a 
commercial HIV Western blot (Dupont-de-Nemours or 
Diagnostics Pasteur) or by a line immunoassay (LIA) 
based on recombinant proteins and synthetic peptides of 
HIV-1 and HIV-2 (INNOLIA HIV-1+2, Innogenetics) 
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Reactive samples from the epidemiological surveys were 
tested for the presence of antibodies to HIV-1 group O 
viruses, as well as indeterminate samples and samples that 
were positive on ELISA but negative on Western blot. In 
addition, the following samples were tested for antibod- 
ies to HIV-1 group O :205 HIV-1 antibody-positive sera 
and 79 indeterminate sera (i.e. ELISA-positive but with- 
out antibodies to HIV envelope proteins by Western 
blot) collected between 1992 and 1994 at the bloodbank 
and the National Laboratory in Libreville; and 409 sera 
(272 HIV-1 confirmed, 226 HIV Western blot indeter- 
minate and 62 HIV ELISA-positive and Western blot- 
negative) from the International Centre of Medical 
Research [Centre International de Recherches Médi- 
cales (CIRM)] in Franceville. A previous study has 
shown that in Africa, and more specifically in Central 
Africa, indeterminate HIV Western blots are relatively 
frequent. They were mainly a result of early ELISA tests 
and the low prevalence in the population studied. These 
are usually considered as non-specific reactions even if a 
seroconversion or a reaction with an HIV variant cannot 
be excluded [20]. Sera were screened by an improved 
ELISA using V3 peptides from HIV-~ANT-~ ,  and 
HIV-lMvp-5 180 followed by confirmation by LIA where 
different biotinylated V3 peptides from various HIV-1 
strains (consensus peptide, Mn, Mal, Eli, ANT-70, MVP- 
5180 and SIVcpz-gab) were applied as a streptavidin 
complex in parallel lines on nylon strips. The V3 ELISA 
and LIA were research products kindly provided by 
Innogenetics. ELISA-reactive sera were also retested in 
the in-house HIV-1 ANT-70 Western blot. Western blot 
strips were prepared as previously described [21]. Sera 
were considered as having antibodies to HIV-1 group O 
if they showed a strong and specific reaction with the 
ANT-70 or MVP-5180 peptide on LIA, and if they have 
also antibodies to the a l 2 0  of HIV-~ANT-~, on Western 
blot. 
Genetic analysis 
A total of 17 virus strains were isolated between 1988 
and 1993, as previously described [22]; 10 strains were 
from Librede. Of these 10 strains, four were isolated 
from asymptomatic seropositive persons identified in the 
general population survey of 1988 (LBV2-3, LBV10-5, 
LBV21-7, LBV23-10); six were collected between 1989 
and 1993 from AIDS patients admitted to the Infectious 
Diseases Department of the General Hospital (VI685 in 
1992, VI1686 in 1992, VI1076 in 1993,.-VI525.in 1990, 
VI526 in 1990, VI354 in 1989). The'seveqjremaining 
strains (G41, G98, G109, G134, G13Sj G139, G141) were 
isolated from AIDS patients living in. F:,pcevdle and 
were collected between 1988 and 1989; ALI 17 persons 
were from Gabon, except for one man who was from 
Niger (strain G98). The results of the genotyping of 
strains LBV21-7 and VI525 have been previously pub- 
lished [14]. VI686 was pre+iously classified in HIV-1 
group O based on phylogenetic analysis of part of the pol 
gene [15]. 
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Preparation of DNA template for polymerase chain 
reaction (PCK) was perfornied as described elsewhere 
[22]. A nested PCR was performed in 50 pl reaction 
mixture containing 50 niniol/l KCI; 10 mniol/l Tris- 
HCl (pH 8.3); 2.5 mmol/l MgCl,; 0.01% gelatin; 
0.2 mniol/l deoxyribonucleotides (dATP, dCTP, dGTP, 
dTTP); 0.4 pmolll of each primer and 1.25 U Taq DNA 
polymerase (Perkin-Elmer Cetus, Zaventem, Belgium). 
Restriction sites were added to the 5' end of the prim- 
ers for cloning purposes. An aliquot corresponding to 
1 pg DNA was subjected to a first PCR round of 35 
cycles. Gabonese isolates were amplified as previously 
described [23] except for strains LBV10-5, G134, G139 
and G141 which were amplified with the outer primers 
WOU26andWOU29 (WOU26:j '-GCATCTCCTATG 
GCAGGAAGAAG-3'; WOU29: 5 '-TGTAAGTCATT 
GGTCTTAAAGGTACCTG-3 ') . Cycling conditions 
were 1 min at 94"C, 1 min at 50°C and 5 min at 72°C in 
a thermal DNA cycler (Perkin-Elmer Cetus). Two 
microlitres of the amplified DNA were subjected to a 
second round of 25 cycles using the inner primers JFES 
and WOU28 (JFES: 5 '-CgctgaattcAGAGCAGAAGAC 
AGTGGCAATG-3 ' WOU28: 5 '-ccgtctagaTTTGAC 
CACCACTTGCCACCCAT-3'). Cycling conditions 
were 1 min at 94"C, 1 min at 55°C and 5 min at 72°C. 
PCR fragments were digested with their respective 
restriction enzymes, electrophoresed on a 1% agarose 
gel, purified, ligated into a pUC18 or pBR322 cloning 
vector and introduced in Escherichia colì. One clone was 
sequenced for each isolate. Purified plasmid DNA 
(Qiagen plasmid kit; Westburg, Leiden, The Nether- 
lands) was used as template and sequencing reactions 
were performed. Electrophoresis and data collection 
were done on a Pharmacia automated laser fluorescence 
sequencer. Sequences were always obtained for both 
DNA strands and additional sequencing was performed 
in case of unsolved ambiguities. 
The 17 Gabonese HIV e n v  sequences were aligned with 
29 previously known sequences of HIV-1 isolates of 
diverse geographical origin and the SIVcpz-gab 
sequence on the basis of primary structure. The previ- 
ously reported HIV-1 sequences are of the strains, LAI, 
MN, SF2, D687, U455, OYI, 2321, NDK, 2226, ELI, 
D747, NOF, CA13, VI557, BZ126, BZ163, LBV21-7, 
V1525, C213, C122, CA4, CA5, CA10, CA16, CA20, 
CM239, CM235, MVP5180, VAU and ANT-70. 
The nucleotide sequence data were deposited in the 
European Molecular Biology Laboratory, GenJ3ank and 
DNA !bata Bank of Japan Nucleotide Sequence Data- 
bases under the following accession numbers. (X90912 
to X90924 and X96526). 
Statistical analysis 
Statistical comparison of the groups was done b x' 
analysis with or without Yates' correction and by x test 
for linear trend. The calculations were performed using 
Y 
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Table 1. HIV seroprevalence rates by years in different population groups 
I 
Years No. tested No. HIV+ (no. HIV-2) HIVt (%) x2 P 
Libreville 
1988 
1990 
1991 
1992 
1993 . 
1994 - 
Infectious Diseases patients 
Tuberculosis patients 
1990 
1992 
1993 
1994 
Pregnant women 
1988 
1993 
1994 
1986 
1988 
1989 
Prisoners 
1986 
1994 
General population 
Franceville 
Pregnant women 
General population 
1986 
1987 
1986 
1988 
125 
99 
74 
190 
156 
220 
199 
120 
35 
123 
539 
530 
1684 
383 
397 
400 
650 
1158 
473 
298 
3 84 
502 
4 
12 
28 
4 
4 
1 
4 
1.6 19.05 0.00001 
3.0 
5.4 
4.7 
5.3 
12.7 
1.5 25.47 0.00001 
9.2 
25.7 
16.2 
0.7 1.1 82 0.28 (NS) 
2.2 
1.7 
2.1 0.23 0.88 (NS) 
2.2 
1.7 
2.1 0.48 (NS) 
2.7 
0.8 0.08 (NS)" 
1.3 
0.3 
0.8 
1.35 (NS)" 
* With Yate's correction. NS, Not significant. 
EpiInfo Programme (5.01 a; Centers for Disease Control 
Epidemiology Program Office, Atlanta, Georgia, USA). 
1994. Among the patients admitted ro the Infectious 
Diseases Department the percentage of HIV-infected 
patients increased &om 1.6% in 1988 to 12.7% in 1994 
(x' for trend, 19.05; P = lo-'). Among the tuberculosis 
patients, the HIV seroprevalence increased from 1.5% in 
1990 to 16.2% in 1994 (x' for trend, 25.47; P =  lo-'). 
HIV prevalence in the different population groups 
Table 1 shows the prevalence data for the groups in dif- 
ferent years. In Libreville, the HIV prevalence among 
pregnant women ranged between 0.7 and 2.2% from 
1988 to 1994, without evidence of a significant increase 
over this 6-year time period. Similarly, the HIV preva- 
lence in the general population remained relatively low 
and stable between 1986 and 1989, ranging between 1.7 
and 2.2%. The prevalence among 1158 prisoners tested 
in 1994 was nearly the same as the prevalence among 
650 prisoners tested in 1986 (2.1 versus 2.7%). The 
prevalence data fiom Franceville also show low levels of 
infection in the general population. In l9BG and 1987 
the HIV infection rates among pr&$antiwomen were 
0.8 and 1.3%, respectively. The @neral population sur- 
veys gave levels of 0.3 and 0.8% in 4'886 and 1988, 
Among patients admitted to the Infectious Diseases 
Department and among tuberculosis patients higher 
HIV prevalences were found than in the generai popula- 
tion, as expected. There & also a marked increase of the 
prevalence in these groups of patients between 1988 and 
.I.\ '5 respectively. ,, 
Of the 226 sera which were HIV-positive, 218 (96.5%) 
were with HIV-1-positive and only eight (3.5%) were 
HIV-2-positive. 
HIV-1 group O antibodies 
A total of 1089 sera were tested for the presence of anti- 
bodies to group O viruses (Table 3). Of these, 185 HIV- 
positive sera were collected in epidemiological surveys. 
Only two of these sera were found to be positive for 
HIV-1 group O, one was &om a patient admitted to the 
Infectious Disease Department in Libreville, in 1992, the 
other was tiom a pregnant woman attending an antena- 
tal clinic in 1993. Both women were Gabonese. In Libre- 
villt, 205 HIV-1-positive and 79 indeterminate sera, col- 
lected beciveen 1992 and 1994 from the blood bank and 
the national laboratory, were negative for group O anti- 
bodies. In Franceville, one out of the 272 HIV-1-positive 
sera fiom CIRM was positive for antibodies to group O, 
but none of the 226 indeterminate and 62 ELISA- 
positive but Western blot-negative sera had group O 
antibodies. The relative fiequency of HIV-1 group O 
I .  . .."I . .b .. . . . ... . . . . 
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Table 2. Number of sera with antibodies to HIV-1 group O among HIV-1-positive, HIV-indeterminant and HIV-negative sera in 
different population groups from Libreville and Franceville. 
Population group 
No. with antibody to 
city Years No. tested HIV group O 
HIV-1 
Infectious Diseases patients 
Tuberculosis patients 
Pregnant women 
General population 
Prisoners 
Blood donors from the Screening 
Pregnant women/ eneral population 
ClRM Screening 6inical Laboratory 
Total 
National Laboratory 
1990-1 994 
1992-1 994 
1988-1 994 
1986-1 989 
1994 
1992-1 994 
1980-1 988 
1988-1 994 
55 
36 
39 
9 
28 
201 
8 
2 72 
648 
Indeterminate 
- Infectious Disease patients L 1990-1 994 1 
- Pregnant women L 1988-1 994 8 
Prisoners L 1994 - 
Blood donors from the Screening 
Total 320 
National Laboratory L 1992-1 994 79 - 
ClRM Screening Clinical Laboratory F 1988-1 994 226 - 
ELISA-positive, WB/LIA-negative 
Infectious Disease patients 
Pregnant women 
Prisoners 
ClRM Screening Clinical Laboratory 
Total 
L 1990-1 994 13 
L 1988-1 994 30 
L 1994 16 
F 1988-1 994 62 
121 
CIRM, Centre International de Recherches Médicales; WB/LIA, Western blot/line immunoassay; L, Libreville; F, Franceville. , . *  
infection in HIV-1-positive sera was therefore 0.5% (two 
out of 390) in Libreville and 0.4% (one out of 272) in 
Franceville. 
Genetic analysis 
The sequence diversity of a 900 base-pair fragment 
encoding part of the env region containing V3, V4 and 
V5 and the beginning of gp41 was studied, and a phylo- 
genetic tree was constructed based on 872 unambigu- 
ously aligned positions. The 17 Gabonese HIV-1 strains 
represent six different genetic subtypes. In the tree (Fig. 
1) eight group M subtypes can be distinguished, contain- 
ing sequences representative for subtypes A to H. Seven 
of the 17 isolates belong to subtype A, supported by 
100% of the bootstrap trees. Four Gabonese.isolates 
(LBV21-7, G98, VI525, VI526) are from sub 
ported by 999 out of 1000 bootstrap trees. ne isolate 
(VI354) clustered with subtype F strains from Brazil and 
Cameroon in 772 out of 1000 bootstrqp tiees. Subtype 
C, supported by all bootstrap trees, consists of two statis- 
tically highly supported clusters; one cluster harbours 
two Gabonese isolates (LBV10-5, G134) and other clus- 
ter contains the South-Mican strain NOF and the strain 
D747. Subtype D, supported by all bootstraps contains 
two Gabonese isolates (G109, G141). Finally, one isolate 
VI686 belonged to group O. 
(VI685, G41, G135,LBV2-3, G139,VI1076, LBV23-10) 
%e G, sup- 
L /  , . .  
Discussion 
The prevalence data of the pregnant women and the 
results of the repeated population surveys indicate that 
between 1986 and 1994 the prevalence of HIV infection 
in the general population of Libreville remained rela- 
tively low and stable. However the time span for which 
data are available is too short to allow us to draw any firm 
conclusions as to the future course of the HIV epidemic 
in Gabon. At this stage it is impossible to say whether 
prevalence levels will remain low or whether the epi- 
demic in Gabon is still in its earlier stages and the preva- 
lence data represent datapoints on the low end of an 
exponential curve which will rise sharply in the next few 
years. However, the increase in HIV prevalence among 
patients admitted to the Infectious Diseases Department 
and among tuberculosis patients suggests that the HIV 
epidemjc in Gabon is s d  in its early stages and may not 
yet ha4e reaclied a plateau. 
Although the results &om the epidemiological studies 
suggest a relatively recent start of the epidemic in Libre- 
ville, the genetic characteristics of the circulating virus 
strains suggest that HIV viruses have been circulating in 
Gabon for a very long time. Our sample size of 17 HIV- 
positive isolates is rather small, yet we were able to docu- 
ment the presence of at least five Merent group M sub- 
-____. , --.- . -._._. 
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Fig. 1 Phylogenetic tree based on 872 unavbiguously aligned position: of HIC1 'envgene sequences from 44 different subjects, 
for which the country code is indicated: and the simian immunodeficiency virus (SIVkpz-gab. The sequences determined in this 
study are indicated in bold type. The distance between two sequences is obtained by summing the lengths of the connecting 
branches using the scale at the top. The number of bootstrap trees out of 1 O00 replications supporting a particular phylogenetic 
group in more than 75% is placed alongside the node considered. 
types as well as one group O subtype. A similar large subtypes A, B, E, F and H are circulating, as well as group 
variety of HIV-1 subtypes has been found in Cameroon O viruses [35]. In the Central African Republic, subtypes 
and the Central African Republic [24]. In Cameroon, A, C, D, E, G and H have been found. The large variety 
. ... . .. &,r.>>:'z'.. i-.. .d.*". " . , .2?....&rE';SL.;;. -. &.i", , 
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of circulating subtypes in Central Africa seems to be 
quite different from what has been found so far in other 
parts of the world, including o t h q  regions of Africa 
[23,26] where, on a similar number of samples, circulat- 
ing strains belong only to a few different HIV-1 sub- 
types. This Co-circulation of all known HIV-1 subtypes 
in Central Africa would be an argument in favour of the 
hypothesis that the HIV viruses somehow originate from 
this part of Africa. 
An additional argument in favour of his hypothesis is the 
isolation of two different HIV-1-like viruses (SIVcpz- 
gab, SIVcpz-gab2) &om naturally infected chimpanzees 
in Gabon. However, the prevalence of SIVcpz infection 
among chimpanzees is probably low, which argues 
against the chimpanzee being the natural host of HIV-1 
viruses [27]. On the other hand, the close phylogenetic 
relationship between HIV-1 and SIVcpz would suggest 
that both humans and chimpanzees are infected by 
viruses fiom a third, as yet unidentified, primate species. 
There are two possible explanations for the large variety 
of subtypes found in humans. The first is that the differ- 
ent subtypes are the result of different, independent 
cross-species transmission events. However this presup- 
poses a high prevalence of the different subtypes in the 
natural host and a high frequency of cross-species trans- 
missions. Alternatively, the different subtypes are the 
result of differentiation within the human host. This in 
turn presupposes that the virus has been circulating for a 
very long time in the human population in Central 
Afiica. In this report, retrospective serologic studies have 
shown that HIV existed in humans as early as the late 
1950s [28]. It is also interesting to note that the first three 
patients with AIDS, described in France in 1978, (i.e. 
before the AIDS epidemic) came from Gabon and 
Congo [29]. 
So, if we can assume that the populations of Gabon have 
been exposed to HIV viruses for a very long time or that 
these viruses have been circulating among humans for a 
number of decades already, or both, how can it then be 
explained that the prevalence levels of HIV infection are 
stdl so low, compared to other regions in Mica  where 
prevalence levels of well over 20% were reached in less 
than 10 years? Several researchers have reflected on the 
paradox that there is molecular evidence that HIV has 
been prevalent in human populations for a very long 
time - over one century according to some estimates 
-yet that it only became apparent over the lytJS years. 
May and Anderson [30] offer a posible qplanation 
based on work with mathematical models: &tial chains 
of infection in relatively isolated populations, such as 
rural dages,  stutter to extinction, but ithrhw off sparks 
that start another chain of infections in another village 
[30]. The number of sparks will increase steady until a 
large-scale epidemic starts off with an exponential 
increase in prevalence levels.-It seems, at least for the time 
being, that the HIV epidemic in Libreville consists of 
multiple 'sparks' or smaller epidemics that are the result 
of outside contact. The reasons why these sparks have 
not yet resulted in a large-scale epidemic such as the ones 
in Abidjan and Kampala E311 are not clear. A survey 
among pregnant women in Libreville carried out in 
1994 found high prevalence rates of other STD: 9% of 
the women had a chlamydial infection, 2% gonococcal 
infection, 18% were found with trichomoniasis and 3% 
were positive for syphilis [32]. These data indicate high 
levels of high-risk sexual behaviour. However, we do not 
have any data on sexual behaviour patterns, more specifi- 
cally sexual mixing patterns and concurrent partner- 
ships, which have been suggested as critical determinants 
of the rate of spread of HIV infection in populations 
[33]. These sexual patterns and concurrent partnerships, 
as well as circumcision status of the male partner, might 
be an important determinant in explaining the differ- 
ences in the course of the HIV epidemic between differ- 
ent parts of Africa. In Gabon, circumcision is commonly 
practised on men, and this factor is believed to be a pro- 
tective factor against the spread of HIV infection. Other 
factors related to the efficiency of virus transmission 
include sexual practises such as intercourse during 
menses or anal intercourse; the presence of another STD; 
condom use; and disease stage of the infected partner. 
Other potential factors involved in the spread of the HIV 
infection could be related to demographic variables and 
genetic characteristics of the virus or the population, or 
both. In countries where the epidemic is spreading dra- 
matically, a massive migration of rural inhabitants to 
urban centres has been fiequently observed [34], but in 
Gabon, at least at present, rapid urbanization is not asso- 
ciated with rapid spread of HIV infection. 
The genetic subtype of the virus can also be a factor in 
the difference of the HIV spread [10,11]. The extent to 
which different subtypes of HIV-1 would play a role in 
the dynamics of HIV-1 in Africa remains unknown, but 
it cannot be excluded that a different genetic HIV-1 sub- 
type could have a different biological behaviour. In East 
Africa [29] and in Côte d'Ivoire [23], where the epi- 
demic has been increasing rapidly, HIV-1 subtype A is 
highly predominant in contrast with Gabon or Cam- 
eroon where the HIV seroprevalence remains stable and 
low and where numerous genetic subtypes of HIV-1 are 
circulating. Is this indicating that subtype A strain is more 
virulent than the other strains and becomes dominant in 
the same way that HIV-1 dominates HIV-2 in some 
West African countries? Or is this indicating that the first 
infectip occurred by subtype A and then in these coun- 
tries social a id  behavioural factors made the epidemic 
explosive? 
Finally, human leukocyte antigen characteristics and 
natural resistance to HIV of some populations is a poten- 
tial factor which has to be considered but for which no 
data are currently available. 
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A better understanding of the reasons for the differences 
in spread of HIV infection is urgently needed for the 
design of more cost-effective interventions to control the 
spread of HIV infection, and'would rhus enable more 
accurate predictions of the future spread of HIV infec- 
tion. 
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